Recent reports have ignited significant questioning regarding Wockhardt’s cough medication, specifically concerning the identification of unacceptable levels of dextromethorphan and other contaminants. While the company previously claimed its adherence to safety, several cases of negative outcomes, including severe neurological damage and even lo